Logo image of ABO.BR

ABO GROUP ENVIRONMENT (ABO.BR) Stock Fundamental Analysis

EBR:ABO - Euronext Brussels - BE0974278104 - Common Stock - Currency: EUR

4.9995  0 (0%)

Fundamental Rating

6

Overall ABO gets a fundamental rating of 6 out of 10. We evaluated ABO against 44 industry peers in the Commercial Services & Supplies industry. While ABO belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ABO is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes ABO very considerable for growth investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ABO had positive earnings in the past year.
ABO had a positive operating cash flow in the past year.
In the past 5 years ABO has always been profitable.
Each year in the past 5 years ABO had a positive operating cash flow.
ABO.BR Yearly Net Income VS EBIT VS OCF VS FCFABO.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

1.2 Ratios

ABO's Return On Assets of 2.78% is in line compared to the rest of the industry. ABO outperforms 59.09% of its industry peers.
ABO's Return On Equity of 9.16% is in line compared to the rest of the industry. ABO outperforms 54.55% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.84%, ABO is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
ABO had an Average Return On Invested Capital over the past 3 years of 6.79%. This is in line with the industry average of 7.49%.
The 3 year average ROIC (6.79%) for ABO is below the current ROIC(7.84%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.78%
ROE 9.16%
ROIC 7.84%
ROA(3y)3.03%
ROA(5y)3.28%
ROE(3y)10.2%
ROE(5y)10.82%
ROIC(3y)6.79%
ROIC(5y)7.33%
ABO.BR Yearly ROA, ROE, ROICABO.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

ABO has a Profit Margin (2.60%) which is in line with its industry peers.
In the last couple of years the Profit Margin of ABO has grown nicely.
ABO has a Operating Margin (5.33%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ABO has grown nicely.
ABO's Gross Margin of 87.31% is amongst the best of the industry. ABO outperforms 90.91% of its industry peers.
In the last couple of years the Gross Margin of ABO has remained more or less at the same level.
Industry RankSector Rank
OM 5.33%
PM (TTM) 2.6%
GM 87.31%
OM growth 3Y-6.44%
OM growth 5Y11.16%
PM growth 3Y-11.25%
PM growth 5Y19.73%
GM growth 3Y-0.84%
GM growth 5Y-0.31%
ABO.BR Yearly Profit, Operating, Gross MarginsABO.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABO is creating some value.
The number of shares outstanding for ABO remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ABO has about the same amount of shares outstanding.
Compared to 1 year ago, ABO has an improved debt to assets ratio.
ABO.BR Yearly Shares OutstandingABO.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ABO.BR Yearly Total Debt VS Total AssetsABO.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

ABO has an Altman-Z score of 2.26. This is not the best score and indicates that ABO is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.26, ABO is in the better half of the industry, outperforming 68.18% of the companies in the same industry.
The Debt to FCF ratio of ABO is 7.35, which is on the high side as it means it would take ABO, 7.35 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 7.35, ABO is doing good in the industry, outperforming 61.36% of the companies in the same industry.
ABO has a Debt/Equity ratio of 0.57. This is a neutral value indicating ABO is somewhat dependend on debt financing.
The Debt to Equity ratio of ABO (0.57) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 7.35
Altman-Z 2.26
ROIC/WACC1.31
WACC5.98%
ABO.BR Yearly LT Debt VS Equity VS FCFABO.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.3 Liquidity

ABO has a Current Ratio of 1.16. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
ABO has a Current ratio of 1.16. This is comparable to the rest of the industry: ABO outperforms 45.45% of its industry peers.
ABO has a Quick Ratio of 1.13. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.13, ABO is doing good in the industry, outperforming 63.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.13
ABO.BR Yearly Current Assets VS Current LiabilitesABO.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 41.21% over the past year.
The Earnings Per Share has been growing by 35.88% on average over the past years. This is a very strong growth
The Revenue has grown by 21.68% in the past year. This is a very strong growth!
Measured over the past years, ABO shows a quite strong growth in Revenue. The Revenue has been growing by 13.50% on average per year.
EPS 1Y (TTM)41.21%
EPS 3Y5.8%
EPS 5Y35.88%
EPS Q2Q%-31.17%
Revenue 1Y (TTM)21.68%
Revenue growth 3Y19.22%
Revenue growth 5Y13.5%
Sales Q2Q%14.27%

3.2 Future

ABO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.28% yearly.
The Revenue is expected to grow by 18.30% on average over the next years. This is quite good.
EPS Next Y30.1%
EPS Next 2YN/A
EPS Next 3Y13.28%
EPS Next 5YN/A
Revenue Next Year8.5%
Revenue Next 2YN/A
Revenue Next 3Y18.3%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABO.BR Yearly Revenue VS EstimatesABO.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 20M 40M 60M 80M 100M
ABO.BR Yearly EPS VS EstimatesABO.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2026 0.1 0.2 0.3 0.4 0.5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 22.73, the valuation of ABO can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ABO is on the same level as its industry peers.
ABO is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.18, which is the current average of the S&P500 Index.
ABO is valuated reasonably with a Price/Forward Earnings ratio of 10.16.
ABO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ABO is cheaper than 77.27% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.81, ABO is valued rather cheaply.
Industry RankSector Rank
PE 22.73
Fwd PE 10.16
ABO.BR Price Earnings VS Forward Price EarningsABO.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ABO is valued a bit cheaper than the industry average as 70.45% of the companies are valued more expensively.
ABO's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 12.96
EV/EBITDA 6.32
ABO.BR Per share dataABO.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

ABO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ABO has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ABO's earnings are expected to grow with 13.28% in the coming years.
PEG (NY)0.75
PEG (5Y)0.63
EPS Next 2YN/A
EPS Next 3Y13.28%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.88%, ABO has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.71, ABO has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.45, ABO is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.88%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3Y13.28%
ABO.BR Yearly Income VS Free CF VS DividendABO.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

ABO GROUP ENVIRONMENT

EBR:ABO (5/2/2025, 7:00:00 PM)

4.9995

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.28%
Inst Owner ChangeN/A
Ins Owners85.52%
Ins Owner ChangeN/A
Market Cap52.84M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.88%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 22.73
Fwd PE 10.16
P/S 0.59
P/FCF 12.96
P/OCF 5.99
P/B 2.09
P/tB 2.97
EV/EBITDA 6.32
EPS(TTM)0.22
EY4.4%
EPS(NY)0.49
Fwd EY9.84%
FCF(TTM)0.39
FCFY7.72%
OCF(TTM)0.84
OCFY16.71%
SpS8.45
BVpS2.39
TBVpS1.68
PEG (NY)0.75
PEG (5Y)0.63
Profitability
Industry RankSector Rank
ROA 2.78%
ROE 9.16%
ROCE 10.38%
ROIC 7.84%
ROICexc 9.51%
ROICexgc 11.86%
OM 5.33%
PM (TTM) 2.6%
GM 87.31%
FCFM 4.57%
ROA(3y)3.03%
ROA(5y)3.28%
ROE(3y)10.2%
ROE(5y)10.82%
ROIC(3y)6.79%
ROIC(5y)7.33%
ROICexc(3y)11.7%
ROICexc(5y)12.37%
ROICexgc(3y)14.41%
ROICexgc(5y)14.93%
ROCE(3y)8.99%
ROCE(5y)9.7%
ROICexcg growth 3Y-12.9%
ROICexcg growth 5Y14.21%
ROICexc growth 3Y-15.31%
ROICexc growth 5Y11.73%
OM growth 3Y-6.44%
OM growth 5Y11.16%
PM growth 3Y-11.25%
PM growth 5Y19.73%
GM growth 3Y-0.84%
GM growth 5Y-0.31%
F-Score6
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 7.35
Debt/EBITDA 1.22
Cap/Depr 67.11%
Cap/Sales 5.32%
Interest Coverage 3.98
Cash Conversion 74.59%
Profit Quality 175.97%
Current Ratio 1.16
Quick Ratio 1.13
Altman-Z 2.26
F-Score6
WACC5.98%
ROIC/WACC1.31
Cap/Depr(3y)71.13%
Cap/Depr(5y)62.13%
Cap/Sales(3y)5.6%
Cap/Sales(5y)5.1%
Profit Quality(3y)140.8%
Profit Quality(5y)194.45%
High Growth Momentum
Growth
EPS 1Y (TTM)41.21%
EPS 3Y5.8%
EPS 5Y35.88%
EPS Q2Q%-31.17%
EPS Next Y30.1%
EPS Next 2YN/A
EPS Next 3Y13.28%
EPS Next 5YN/A
Revenue 1Y (TTM)21.68%
Revenue growth 3Y19.22%
Revenue growth 5Y13.5%
Sales Q2Q%14.27%
Revenue Next Year8.5%
Revenue Next 2YN/A
Revenue Next 3Y18.3%
Revenue Next 5YN/A
EBIT growth 1Y58.61%
EBIT growth 3Y11.53%
EBIT growth 5Y26.17%
EBIT Next Year117.93%
EBIT Next 3Y42.23%
EBIT Next 5YN/A
FCF growth 1Y243.93%
FCF growth 3Y-16.35%
FCF growth 5Y34.22%
OCF growth 1Y66.41%
OCF growth 3Y-3.94%
OCF growth 5Y18.54%